These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 3TC: now available again up to CD4 of 300. AIDS Treat News; 1995 Aug; (no 228):4. PubMed ID: 11362624 [TBL] [Abstract][Full Text] [Related]
3. Lamivudine (3TC) approved for combination use with AZT. James JS AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049 [TBL] [Abstract][Full Text] [Related]
8. A closer look at 3TC. Interview by Mark Mascolini. Rubin M J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724 [TBL] [Abstract][Full Text] [Related]
9. Another option for less than 50 T4 cells. Treat Rev; 1995; (no 19):3. PubMed ID: 11362755 [TBL] [Abstract][Full Text] [Related]
16. 3TC expanded access program: new requirement for CD4 less than 100. AIDS Treat News; 1995 May; (no 222):5. PubMed ID: 11362463 [TBL] [Abstract][Full Text] [Related]
17. Glaxo broadens access to 3TC. Baker R BETA; 1995 Sep; ():5. PubMed ID: 11362896 [TBL] [Abstract][Full Text] [Related]
18. 3TC approved: now for the tough questions. Mascolini M J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101 [TBL] [Abstract][Full Text] [Related]
19. 3TC: the good news and the bad news. Cheng B PI Perspect; 1995 May; (no 16):4. PubMed ID: 11362426 [TBL] [Abstract][Full Text] [Related]
20. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James. Poscher M AIDS Treat News; 1995 Jul; (no 226):2-4 contd. PubMed ID: 11362613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]